InvestorsHub Logo
Followers 1
Posts 31
Boards Moderated 0
Alias Born 08/23/2013

Re: MolBiol post# 5223

Tuesday, 03/04/2014 7:57:24 PM

Tuesday, March 04, 2014 7:57:24 PM

Post# of 732802
Almost no chance to hold the trail for futility at this very early stage.

I have to remind you that the phase II trial of IMUC did not meet its primary endpoint in the final analysis by a large margin but it wasn't killed in the interim analysis.

Unless dcvax-L facilitates tumor, it won't be stopped at 66 events not to mention that are many endpoints built in the trail. It is hard to imagine dcavx-L missed all of them.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News